Atlas Trials

Glomerulonephritis Minimal Lesion

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Glomerulonephritis Minimal Lesion

RecordFirmDate
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease (NCT06500702)Sanofi2024-12-19

Track Glomerulonephritis Minimal Lesion automatically

Every clearance here is in the API, with alerts when new ones post.